FIRST COMBINATION OF A NON-ELECTRIC INFUSION PUMP WITH SELECTABLE RATE FLOW CONTROL FOR INTRAVENOUS AND SUBCUTANEOUS USE.
INTRAVENOUS INFUSION THERAPY
Safe, effective, simplified, groundbreaking non-electric medication delivery.
Learn more about intravenous infusion therapy using Insignis™
SUBCUTANEOUS INFUSION THERAPY
A new medical paradigm: convenience, safety, innovation, and autonomy as the patient now can select, titrate, and/or modify the flow rate in real-time
Learn more about subcutaneous infusion therapy using Insignis™
![](/wp-content/uploads/2022/05/icon.png)
![](/wp-content/uploads/2022/05/icon1.png)
![](/wp-content/uploads/2022/05/icon2.png)
![hexagon](https://www.innohealthsci.com/wp-content/uploads/2022/11/hexagon.png)
New Infusion Approach: Better Infusion Performance.
The Insignis™ system delivers the performance, convenience, and accuracy of electronic systems and is designed to be:
- Portable
- Cost-effective
- Mechanical
- Simple to use
- Highly accurate
- Safe, low pressure
- Versatile
- Reliable
Learn more about our products
A Company Purposefully Built to Advance Infusion Technologies
In 2019, renowned medical engineer and inventor Andy Sealfon launched IHS to make a meaningful difference for patients worldwide. Some of these patients-who require ongoing lg replacement, or IV antibiotic therapy-were burdened by equipment that was expensive, hard-to-use and often imprecise, which hindered their mobility or made it difficult to administer and control their treatments.
Today, Innovative Health Sciences [IHS] are solving these problems at the forefront of infusion technology. We are creating cutting-edge, innovative products – like the Insignis Syringe Infusion System – that bring measurable value throughout the entire infusion market.
![home-products](https://www.innohealthsci.com/wp-content/uploads/2022/12/home-products.jpg)
News
IHS Expands Team to Market Insignis™ Syringe Infusion System after Receiving FDA Clearance
CHESTER, N.Y., Aug. 5, 2024 /PRNewswire/ -- Innovative Health Sciences ("IHS" or the "Company"), a medical device company that creates state-of-the-art drug infusion solutions, announced today the expansion of its commercialization team to market the Insignis™ Syringe...
Innovative Health Sciences Receives FDA Clearance for Insignis™ Subcutaneous Needle Sets
CHESTER, N.Y. (August 26, 2021) – Innovative Health Sciences, LLC (“IHS” or the “Company”) management announced today that IHS has received FDA clearance for its Insignis™ Subcutaneous Needle Sets. This regulatory clearance allows IHS to sell and distribute its...
Innovative Health Sciences to Showcase its State-of-the-Art Insignis™ Syringe Infusion System at Medica 2021
CHESTER, N.Y. (November 12, 2021) Innovative Health Sciences, LLC (“IHS” or the “Company”) will be presenting its breakthrough versatile and low cost non-electric infusion system at Medica, a world-renowned trade fair for medical devices and medical technologies,...